NCT03898297View on ClinicalTrials.gov

Imaging mGluR5 and Synaptic Density in Psychiatric Disorders

Active, not recruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

January 11, 2017

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Major Depressive DisorderBipolar DisorderHealthy
Interventions
RADIATION

[18F]FPEB

Radiotracer: \[18F\]FPEB

RADIATION

[11C]APP311

Radiotracer: \[11C\]APP311, \[11C\]UCB-J

Trial Locations (1)

06519

Yale University PET Center, New Haven

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT03898297 - Imaging mGluR5 and Synaptic Density in Psychiatric Disorders | Biotech Hunter | Biotech Hunter